Scott Schoenhaus
Stock Analyst at Keybanc
(2.16)
# 2,899
Out of 5,005 analysts
112
Total ratings
39.8%
Success rate
-2.91%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Overweight | $14 → $12 | $6.97 | +72.17% | 4 | Aug 6, 2025 | |
| SLP Simulations Plus | Downgrades: Sector Weight | n/a | $16.02 | - | 5 | Jul 15, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $45 → $60 | $51.29 | +16.98% | 2 | Jul 14, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $106 → $93 | $64.03 | +45.24% | 1 | Jul 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $70 | $73.26 | -4.45% | 4 | Jul 14, 2025 | |
| CERT Certara | Maintains: Overweight | $18 → $15 | $13.07 | +14.77% | 5 | Jul 14, 2025 | |
| ALB Albemarle | Maintains: Overweight | $95 → $87 | $88.22 | -1.38% | 1 | Jul 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $5 → $10 | $5.90 | +69.49% | 6 | Jul 14, 2025 | |
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $20.59 | +55.42% | 5 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $23.27 | +20.33% | 7 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $52 → $50 | $59.28 | -15.65% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $88.59 | +12.88% | 5 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.96 | +68.92% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $9 | $3.38 | +166.27% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $296.28 | -13.93% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $5.49 | +82.15% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $4.53 | +32.45% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.76 | +63.04% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $3.27 | +236.39% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $20.59 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $30.95 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $9.01 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $206.63 | +20.99% | 2 | Apr 16, 2021 |
LifeMD
Aug 6, 2025
Maintains: Overweight
Price Target: $14 → $12
Current: $6.97
Upside: +72.17%
Simulations Plus
Jul 15, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $16.02
Upside: -
Hinge Health
Jul 14, 2025
Maintains: Overweight
Price Target: $45 → $60
Current: $51.29
Upside: +16.98%
Eastman Chemical Company
Jul 14, 2025
Maintains: Overweight
Price Target: $106 → $93
Current: $64.03
Upside: +45.24%
Doximity
Jul 14, 2025
Maintains: Overweight
Price Target: $65 → $70
Current: $73.26
Upside: -4.45%
Certara
Jul 14, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $13.07
Upside: +14.77%
Albemarle
Jul 14, 2025
Maintains: Overweight
Price Target: $95 → $87
Current: $88.22
Upside: -1.38%
AbCellera Biologics
Jul 14, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $5.90
Upside: +69.49%
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $20.59
Upside: +55.42%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $23.27
Upside: +20.33%
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $59.28
Upside: -15.65%
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $88.59
Upside: +12.88%
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $2.96
Upside: +68.92%
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $3.38
Upside: +166.27%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $296.28
Upside: -13.93%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $5.49
Upside: +82.15%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $4.53
Upside: +32.45%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.76
Upside: +63.04%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $3.27
Upside: +236.39%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $20.59
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $30.95
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $9.01
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $206.63
Upside: +20.99%